Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2355 (LINC02355)

Target
LINC02355
Molecular classification
Long intergenic non-coding RNA (lincRNA), long non-coding RNA (lncRNA)
01

Overview

LINC02355 is a long intergenic non-protein coding RNA gene in humans. Long intergenic non-coding RNAs (lincRNAs) are autonomously transcribed RNAs longer than 200 nucleotides that do not overlap annotated coding genes[3]. LincRNAs can regulate chromatin remodeling, genome architecture, transcription, and RNA stability, often with tissue-specific roles and fine-tuning gene expression in certain cellular contexts[3]. Only a small fraction of lincRNAs have been well-characterized, and LINC02355 does not currently have specific functional, disease, or drug interaction data available in public databases[1][5]. Its classification is based on transcript annotation rather than protein coding, making it distinct from traditional therapeutic targets such as receptors and enzymes. If further research identifies functional roles for LINC02355 in disease or biological pathways, its status as a therapeutic target could change; however, as of now, it is not considered a druggable target.

Other names
LINC02355long intergenic non-protein coding RNA 2355
02

Mechanism of action

Not applicable, as no drugs are reported to interact with LINC02355

03

Biological functions

Chromatin remodelingRegulation of genome architectureTranscription regulation (including enhancer-associated activity)RNA stabilization

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2355 (LINC02355).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2355 (LINC02355).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call